Cannabidiol prevention of cognitive deficits in a rat model for Alzheimer’s disease is associated with neuroinflammationRoni Shira Toledano, Irit Akirav
LOU/c/Jall rat as a resilience model in the context of sporadic Alzheimer’s disease induced by streptozotocinLucas Gephine, Emna Marouane, Stacy Largillière et al.
Metformin inhibits orofacial neuropathy through p-AMPK/p-mTOR-mediated p-p38 MAPK activation in streptozotocin-induced diabetic neuropathic miceJihee Yeo, Roh Dea-Hyun
Protective effects of intracranial stimulation on spatial memory and changes in miRNA serum levels in a sporadic rat model of Alzheimer disease: A longitudinal studyAndrea Riberas Sánchez, Soleil Garcia Brito, Gemma Carreras Badosa et al.
Reduced light exposure as a lifestyle measure for the alleviation of diabetes-induced anxiety – the link with oxidative stressDusan Mladenovic, Dolika Vasovic, Nikola Sutulovic et al.
Retinal and behavioral characterization of a streptozotocin-induced diabetes type 2 model in the search of early symptoms of Alzheimer’s diseaseGeorg Ladurner, Daurer Magdalena, Roland Rabl et al.
Type one diabetes modifies tau phosphorylation patterns and worsens cognitive impairment in the APP/PS1 mouse model of Alzheimer’s diseaseMiriam Corraliza-Gomez, Maria Vargas-Soria, Carmen Infante-Garcia et al.